---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-049999"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2026-11-04T22:28:34+00:00"
generated_at: "2026-11-04T22:30:07.381453+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bio Green Med gets Nasdaq bid-price notice; 180 days to April 27, 2027 to top $1.00

## Summary
- Nasdaq notice Oct 29, 2026: BGMS bid below $1.00 for 30 straight business days, breaching Listing Rule 5550(a)(2).
- 180-day grace period runs to April 27, 2027; compliance requires 10 consecutive closes at or above $1.00.
- Company cites a reverse split of 1:4 to 1:16, subject to stockholder approval, as a potential remedy tied to the FNRG deal.
- June 4, 2026 BCA with Malaysia's Future NRG Sdn. Bhd. would make FNRG a wholly owned subsidiary via share exchange.
- No immediate effect on trading; S-4 proxy/prospectus effective Oct 8, 2026; signed by CEO Datuk Dr. Doris Wong Sing Ee.

## SEC filing metadata
- accession: 0001493152-26-049999
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2026-11-04T22:28:34+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000149315226049999/0001493152-26-049999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000149315226049999/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-049999
- JSON: https://secwatch.observer/filing/0001493152-26-049999.json
- Plain text: https://secwatch.observer/filing/0001493152-26-049999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.